Allison Betof Warner:

Assistant Professor of Medicine (Oncology), Director, Melanoma Medical Oncology Program, Director, Solid Tumor Cellular Therapy Leader, Melanoma & Cutaneous Oncology Clinical Research Group, Stanford University School of Medicine, Stanford Cancer Center, Stanford, CA, US

Axel Bex:

Consultant Clinical Lead Specialist Centre for Kidney Cancer The Royal Free London NHS Foundation Trust, Associate Professor UCL Division of Surgical and Interventional Science, Pond Street, London; Urologic surgeon, The Netherlands Cancer Institute (NKI)/Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, The Nethererlands

Tullia Bruno:

Assistant Professor Researcher, UPMC Hillman Cancer Center, Pittsburgh, PA, US

Corrado Caracò:

Direttore F.F. del Dipartimento Melanoma, Tessuti molli, Muscolo-Scheletrico e Testa-Collo, Istituto Nazionale Tumori, Fondazione G. Pascale di Napoli

Tina Cascone:

Associate Professor and Director of Translational Research, Department of Thoracic/Head & Neck Medical Oncology, Regular Faculty Member, Immunology and Cancer Biology Programs, Graduate School of Biomedical Sciences (GSBS), The University of Texas MD Anderson Cancer Center, Houston, TX, US

Giuseppe Curigliano:

Head Division of Early Drug Development, European Institute of Oncology, Milan; Full Professor of Medical Oncology at University of Milano, Milan, Italy

Julie S. Deutsch:

Assistant Professor of Dermatology and Pathology, Johns Hopkins University, School of Medicine, Baltimore, MD, US

Leisha A. Emens:

Medical Oncologist, indipendent consultant specialist in breast cancer -Pittsburgh, PA, US

Gerardo Ferrara:

Chief, Anatomic Pathology and Cytopathology Unit, National Cancer Institute IRCCS “Fondazione G. Pascale”, Naples, Italy

Jeffrey E. Gershenwald:

John M. Skibber Endowed Professor, Department of Surgical Oncology, Medical Director, Melanoma and Skin Cancer; Distinguished Senior Lecturer, The University of Texas MD Anderson Cancer Center, UT Health Houston Graduate School of Biomedical Sciences, Houston, TX, US

Neil D. Gross:

Professor, Department of Head and Neck Surgery, Division of Surgery Section Chief, Oropharynx Cancer, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, US

Omid Hamid:

Chief, Translational Research & Immuno-Oncology; Director, Cutaneous Malignancies; The Angeles Clinic and Research Institute, Los Angeles, CA, US ; Director of Experimental Therapeutics, Cedars-Sinai Medical Care Foundation, Santa Monica, CA, US

Theresa LaValee:

Chief Development Officer, Coherus BioSciences, Redwood City, CA, US

Georgina V. Long:

Medical Director, Melanoma Institute Australia, Chair of Melanoma Medical Oncology and Translational Research at Melanoma Institute Australia, The University of Sydney, North Sydney, NSW, Australia

Yohann Loriot :

Professor of Medicine, Paris-Saclay University; Deputy Chair of the Department of Early Drug Development, Gustave Roussy, Villejuif, France

Minke Lucas:

MD, The Netherlands Cancer Institute, Amsterdam, Netherlands

Riccardo Masetti:

Direttore dell’Unità Operativa Complessa di Chirurgia Senologica e del Centro di Senologia del Policlinico Gemelli, Roma, Italy

Sapna Patel:

Dr William Robinson Endowed Chair in Cancer Research, Director of Cutaneous Oncology; Professor of Medicine and Ophthalmology, University of Colorado, Aurora, CO, US

Piergiorgio Pettazzoni:
Director Head of Drug discovery Biology, TRACTION MD Anderson Cancer Center, Houston, TX, US

Filippo Piterantonio*:

Direttore della s.s. Oncologia medica gastroenterologica, afferente alla s.c. Oncologia medica 1 presso Fondazione IRCCS Istituto Nazionale dei Tumori di Milano.

Jennifer Seligmann*:

Professor of Gastrointestinal and Translational Oncology and Honorary Consultant in Medical Oncology at the University of Leeds, UK.

Janis M. Taube:

Director, Division of Dermatopathology, Professor of Dermatology, Johns Hopkins University, School of Medicine, Baltimore, MD, US

Hussein A. Tawbi:

Professor; Deputy Chair, Department of Melanoma Medical Oncology; Co-Director, Andrew M. McDougall Brain Metastasis Clinic & Program; Melanoma Medical Oncology; Investigational Cancer Therapeutics; UT MD Anderson Cancer Center, Houston, TX, US

Michael T. Tetzlaff:

Professor of Pathology and Dermatology, Departments of Pathology and Dermatology, The University of California, San Francisco, US

Andrea Vecchione:

Full Professor of Pathological Anatomy, Director UOC Morphological and Molecular Pathological Anatomy,Faculty of Medicine and Psychology,Department of Clinical and Molecular Medicine, University of Rome La Sapienza c/o Azienda Ospedaliero-Universtaria Sant’Andrea, Rome, Italy

*Speakers invited